Cytori Therapeutics, Inc. (CYTX) Recognized by Frost & Sullivan for Medical Device and Regenerative Medicine Innovation  
2/27/2008 8:47:53 AM

SAN DIEGO--(BUSINESS WIRE)--Frost & Sullivan awarded Cytori Therapeutics, Inc. (NASDAQ:CYTX) the 2008 North American Regenerative Medicine Technology Innovation of the Year Award and the 2008 United States Medical Device Industry Innovation & Advancement of the Year Award. The two distinct awards recognize Cytori’s development and commercialization of its Celution™ System platform and its potential to dominate the practice of regenerative medicine.